SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039041
Filing Date
2023-08-07
Accepted
2023-08-07 16:05:04
Documents
84
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kdny-20230630.htm   iXBRL 10-Q 3712737
2 EX-3.1 kdny-ex3_1.htm EX-3.1 16961
3 EX-10.1 kdny-ex10_1.htm EX-10.1 312419
4 EX-31.1 kdny-ex31_1.htm EX-31.1 20281
5 EX-31.2 kdny-ex31_2.htm EX-31.2 20272
6 EX-32.1 kdny-ex32_1.htm EX-32.1 11005
  Complete submission text file 0000950170-23-039041.txt   13292715

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kdny-20230630.xsd EX-101.SCH 75853
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kdny-20230630_pre.xml EX-101.PRE 399744
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kdny-20230630_cal.xml EX-101.CAL 61448
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kdny-20230630_def.xml EX-101.DEF 215231
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kdny-20230630_lab.xml EX-101.LAB 544319
78 EXTRACTED XBRL INSTANCE DOCUMENT kdny-20230630_htm.xml XML 2775448
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 231147542
SIC: 2834 Pharmaceutical Preparations